tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2022 Nov 3;2132798.
doi: 10.1080/21645515.2022.2132798. Online ahead of print.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
Xiaoqiang Liu[SUP] 1 [/SUP], Juliana Park[SUP] 2 [/SUP], Shengli Xia[SUP] 3 [/SUP], Bin Liang[SUP] 4 [/SUP], Shuangmin Yang[SUP] 1 [/SUP], Yanxia Wang[SUP] 3 [/SUP], Olga Syrkina[SUP] 5 [/SUP], Nathalie Lavis[SUP] 6 [/SUP], Shuzhen Liu[SUP] 7 [/SUP], Chenyan Zhao[SUP] 7 [/SUP], Jian Ding[SUP] 4 [/SUP], Jieqiong Hu[SUP] 2 [/SUP], Sandrine I Samson[SUP] 6 [/SUP], Iris A de Bruijn[SUP] 8 [/SUP], FSQ01 and FSQ02 Study Groups; FSQ01 and FSQ02 Study Groups; Lili Huang, Xiaoling Li, Qiang Liu, Hongzhuan Luo, Qinfen Lv, Meihui Su, Zhiqiang Xie, Huacheng Xia, Wangyang You, Wei Zhang, Youmei Zheng, Guangjie Zhu, Zhongyi Zhang, Huiquan Zhang, Karina Abalos, Yann-Joel Beyer, Michael Zhang, Catherine Moreau, Cathy Deng, Camille Salamand, Cynthia Tabar, Rui Ao, Tamala Mallett Moore, Alexandra Jouve, Carina Frago, Rongna A, Erah Jean Baria, Salamand Camille, Xu Cao, Danette Cathcart, Anne-Laure Chabanon, Nong Chen, Huimei Feng, Anne-Isabelle Fontvieille, Audrey Hagenbach, Huan He, Ajinkya Inamdar, Helene Janosczyk, Angeline Lau, Céline Petit, Wilhelm Philippe, Stephanie See, Laurence Serradell-Vallejo, Anne Tourault, Shuyu Wu, Meng Yan, Chenyan Yue, Xinwei Zhang, Hui Zhang, Yuanju Zhu, Jianfen Li, Haiyan Mao, Haitao Yang, Yan Yang, Xiang Yi, Zhixiang Du, Lizhen Guo, Kai Wang
Affiliations
Abstract
Who universal trial numbers (utns): U1111-1174-4615 and U1111-1174-4698.
Clinicaltrials.gov: NCT04210349 and NCT03430089.
Keywords: China; elderly; immunogenicity; inactivated influenza vaccine; pediatric; quadrivalent; safety.
. 2022 Nov 3;2132798.
doi: 10.1080/21645515.2022.2132798. Online ahead of print.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
Xiaoqiang Liu[SUP] 1 [/SUP], Juliana Park[SUP] 2 [/SUP], Shengli Xia[SUP] 3 [/SUP], Bin Liang[SUP] 4 [/SUP], Shuangmin Yang[SUP] 1 [/SUP], Yanxia Wang[SUP] 3 [/SUP], Olga Syrkina[SUP] 5 [/SUP], Nathalie Lavis[SUP] 6 [/SUP], Shuzhen Liu[SUP] 7 [/SUP], Chenyan Zhao[SUP] 7 [/SUP], Jian Ding[SUP] 4 [/SUP], Jieqiong Hu[SUP] 2 [/SUP], Sandrine I Samson[SUP] 6 [/SUP], Iris A de Bruijn[SUP] 8 [/SUP], FSQ01 and FSQ02 Study Groups; FSQ01 and FSQ02 Study Groups; Lili Huang, Xiaoling Li, Qiang Liu, Hongzhuan Luo, Qinfen Lv, Meihui Su, Zhiqiang Xie, Huacheng Xia, Wangyang You, Wei Zhang, Youmei Zheng, Guangjie Zhu, Zhongyi Zhang, Huiquan Zhang, Karina Abalos, Yann-Joel Beyer, Michael Zhang, Catherine Moreau, Cathy Deng, Camille Salamand, Cynthia Tabar, Rui Ao, Tamala Mallett Moore, Alexandra Jouve, Carina Frago, Rongna A, Erah Jean Baria, Salamand Camille, Xu Cao, Danette Cathcart, Anne-Laure Chabanon, Nong Chen, Huimei Feng, Anne-Isabelle Fontvieille, Audrey Hagenbach, Huan He, Ajinkya Inamdar, Helene Janosczyk, Angeline Lau, Céline Petit, Wilhelm Philippe, Stephanie See, Laurence Serradell-Vallejo, Anne Tourault, Shuyu Wu, Meng Yan, Chenyan Yue, Xinwei Zhang, Hui Zhang, Yuanju Zhu, Jianfen Li, Haiyan Mao, Haitao Yang, Yan Yang, Xiang Yi, Zhixiang Du, Lizhen Guo, Kai Wang
Affiliations
- PMID: 36328438
- DOI: 10.1080/21645515.2022.2132798
Abstract
Who universal trial numbers (utns): U1111-1174-4615 and U1111-1174-4698.
Clinicaltrials.gov: NCT04210349 and NCT03430089.
Keywords: China; elderly; immunogenicity; inactivated influenza vaccine; pediatric; quadrivalent; safety.